SCHEMBL6312157

SCHEMBL6312157

Cc1c(O)cccc1-c1ccn(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
TRPA1 O75762 1/20 0.41
ATM Q13315 1/20 0.41
CASP6 P55212 1/20 0.40
MPO P05164 1/20 0.38
CYP3A4 P08684 1/20 0.38
KEAP1 Q14145 1/20 0.38
HSD17B13 Q7Z5P4 1/20 0.36
NT5E P21589 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
TGFBR1 P36897 1/20 0.36
JMJD6 Q6NYC1 2/20 0.35
KDM4A O75164 1/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 2/20 0.34
IDO1 P14902 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1095492 0.85 KMT2A (0.55) KMT2ACASP6KEAP1NT5EADRA1D
SCHEMBL16963173 0.84 AR (0.41) KMT2ACASP6MPOCYP3A4KEAP1
Hydrochloric Acid SCHEMBL30549511 0.83 KMT2A (0.53) KMT2ACASP6KEAP1NT5EADRA1D
SCHEMBL18378772 0.81 KMT2A (0.47) KMT2ATRPA1ATMMPOCYP3A4
SCHEMBL16964095 0.81 KMT2A (0.43) KMT2ACASP6KEAP1NT5EADRA1D
SCHEMBL3319361 0.77 KMT2A (0.40) KMT2ACASP6KEAP1
SCHEMBL19589424 0.76 MPO (0.46) KMT2ACASP6MPOCYP3A4KEAP1
SCHEMBL18367714 0.76 KMT2A (0.42) KMT2ACASP6MPOCYP3A4KEAP1
SCHEMBL5754567 0.76 APLNR (0.45) KMT2AMPOCYP3A4KEAP1TSHR
SCHEMBL17194964 0.76 KMT2A (0.42) KMT2ACASP6MPOCYP3A4KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043300-A1 Piperazine derivatives PFIZER INC. 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043300-A1 Piperazine derivatives CD4, CCR5, RRP15 KMT2A 2921/4885TRPA1 419/4885ATM 4814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.